Topical Skin Adhesive Market Production, Import, Export and Consumption Forecast & Regional Analysis by 2028


17 Jun 2019 - The Global Topical Skin Adhesive Market is anticipated to grow at a significant CAGR during the forecast period. FDA approves cyanoacrylate topical skin adhesives that are particularly indicated for topical applications for skin edges from surgical incisions arising from minimally invasive surgeries. Topical skin adhesives can be used along with dermal stitches and deep cuts. Topical skin adhesives constantly strive to gain acceptance as an effective alternative for sutures and clips pertaining to a wide variety of medical applications. The products have broader benefits over conventional closure techniques for patient and clinician.

         

Topical skin adhesives enable a faster wound closure and restores the skin texture along with cosmetic benefits as compared to conventional wound closure techniques such as sutures. TSA’s are widely used against microbial barriers to protect the wound from contamination against primary closure. It is effective and prevent contaminants till the adhesive film remains undamaged.

Topical skin adhesive market is driven by surge in consumer demand for skin adhesives owing to skin injuries and skin wounds. In addition, a skin adhesive is a better alternative for sutures, clips or staples in case of skin wounds. The market is heavily loaded with ointments and herbal creams which are easily available in the commercial market.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/topical-skin-adhesive-market

Topical skin adhesive market is segmented by type into 2-octyl-cyanoacrylate, 2-ethyl-cyanoacrylate and N-2-Butyl-cyanoacrylate. 2-octyl-cyanoacrylate adhesive is anticipated to dominate the market growth during the forecast period. By application, market is segmented as outdoor medical and surgical.

Geographical segmentation for the market are North America, South America, Europe, Asia-Pacific, Middle East and Africa. Asia-Pacific regions are likely to gain a momentum in the forecast period owing to presence of medical infrastructure and key players. North American and European markets are likely to gain a higher share due growing importance of skin adhesives and presence of key players engaged in manufacture and supply of skin adhesives

The key players profiled in the topical skin adhesive market report are Advanced Medical Solutions Group Plc, Adhezion Biomedical, Beijing Compont Medical Devices Co Ltd, Cartell Chemical Co Ltd, Chemence Medical Inc, GluStitch Inc, Meyer-Haake GmbH,Pfizer, Medtronic, Ethicon LLC, Medline Industries, OptMed and B.Braun.

Market Segment:

Leading players of Topical Skin Adhesive including:

• J&J (Ethicon)
• Medtronic
• Advanced Medical Solutions
• Medline
• B. Braun (Aesculap)
• Chemence Medical
• Adhezion Biomedical
• Compont Medical Devices
• GluStitch Inc
• Meyer-Haake
• Cartell Chemical

Market split by Type, can be divided into:

• 2-Octyl Cyanoacrylate Adhesive
• N-2-Butyl-Cyanoacrylate Adhesive
• 2-Ethyl-Cyanoacrylate Adhesive

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/topical-skin-adhesive-market/request-sample




Location: B730, Ayr KA6 7EN, UK

Comments

Post a Comment

Popular posts from this blog

Thermal Interface Materials Market Revenue, Share and Growth Rate to 2030

  The global thermal interface materials (TIMs) market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.89 billion by 2030, registering a strong CAGR of 11.6% from 2025 to 2030. Growth in this market is primarily driven by the increasing adoption of consumer electronics such as smartphones, laptops, gaming systems, and wearable devices, which require efficient heat dissipation to maintain performance. Similarly, the rising use of industrial automation technologies in developing economies, combined with the growing disposable income of the middle-class population, is significantly boosting demand for TIMs. These materials are specifically engineered to be applied between two hard surfaces often between electronic components and heat sinks to facilitate efficient heat conduction, ensuring safe operation even as devices become smaller, faster, and more powerful. The diverse commercial availability of TIMs in multiple formats, including grea...
Read more

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more